About This Initiative
This educational initiative will review the complex pathophysiology and clinical presentation of patients with eosinophilic esophagitis as well as recent guideline recommendations for the treatment. Although there are currently no FDA-approved therapies for EoE, current and emerging treatments will be explained, as will the critical role pharmacists play in patient counseling, assisting with access to medications, and optimizing overall care.
On-demand Activity
Eosinophilic esophagitis (EoE) is a rare disease that has only been distinguished from gastrointestinal reflux disease since the mid-1990s. This live virtual symposium reviews the complex pathophysiology and clinical presentation of patients with EoE, including recent guideline recommendations for the treatment of EoE. Successful treatment of EoE hinges on an interprofessional approach to care. This activity also provides an interprofessional treatment plan for a patient with EoE, highlighting the pharmacist’s role.
Ask the Experts On-demand Activity
Join our expert faculty for this follow-up webinar addressing questions and comments from previous activity participants.
Engaging the Experts Podcasts
Eosinophilic Esophagitis: The Role of Allergy Testing and Dietary Interventions
Listen NowWhere Do We Go from Here? Discussing the Future of Eosinophilic Esophagitis Treatment
Listen NowExpert Insight Commentaries
Eosinophilic Esophagitis: The New Kid on the Block
Pediatric Eosinophilic Esophagitis: Potentially Big Concerns for Little Patients
View Expert Insight